Skip to Main Content

Paper Details

A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).
J Neurooncol
40
2014
Author NameAffiliation
Camilo E FadulDartmouth-Hitchcock Medical Center, One Medical Center Drive
  • 1 - 1

Datasets

Release 1.2